Arkolith/Insider Trading/AVLN/Form 4

FMR LLC

10% OwnerAvalyn Pharma Inc. (AVLN) · full profile →Form 4 · filed May 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
5 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Conversion(C)728K——728K
May 1, 2026Conversion(C)80K——808K
May 1, 2026Conversion(C)873K——1.7M
May 1, 2026Conversion(C)226K——1.9M
May 1, 2026Conversion(C)378K——2.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2026Conversion(C)728K——0
May 1, 2026Conversion(C)80K——0
May 1, 2026Conversion(C)873K——0
May 1, 2026Conversion(C)226K——0
May 1, 2026Conversion(C)378K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-205201) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML